SIC
NUVB icon

SJS Investment Consulting’s Nuvation Bio NUVB Stock Holding History

SJS Investment Consulting’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.7K Buy
+299
New +$1.46K ﹤0.01% 1840

Other funds holding NUVB

ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

SJS Investment Consulting's NUVB Position: Q2 2026 in Review

SJS Investment Consulting opened a new position in Nuvation Bio (NUVB) in Q2 2026: 299 shares worth $1.7K. The stake represents ﹤0.01% of the portfolio and ranks #1840 among its holdings.

43 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • SJS Investment Consulting held 299 shares of Nuvation Bio worth $1.7K as of Q2 2026.
  • Nuvation Bio was a new SJS Investment Consulting position in Q2 2026.
  • Nuvation Bio made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1840 holding.
  • 43 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.